Our study included a relatively small number of patients and the follow-up period was too short to draw definite conclusions regarding the possible relationship between the serum hepcidin-25 level or tumor hepcidin mRNA expression and the prognosis of RCC. The gene discussed is HAMP; the disease is neoplasm.